BANK OF AMERICA CORP /DE/
BankPosition in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in AMLX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$18,496,576
+$2,357,577 QoQ
Shares Held
1,330,689
-0.4% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 82%
Shared 0%
None 18%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $1,773,009,188 across 50 Drug Manufacturers - Specialty & Generic names. AMLX ranks #18 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,831,652 | $571,149,579 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,958,814 | $119,239,475 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
199,426 | $118,255,627 | |
| 4 | HLN |
Haleon plc
|
10,934,228 | $109,451,619 | |
| 5 | VTRS |
Viatris Inc
|
7,259,555 | $98,076,585 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
4,357,672 | $90,465,268 | |
| 7 | LQDA |
Liquidia Corp
|
2,287,792 | $86,341,267 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,358,215 | $80,362,082 |
All Filings in AMLX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,496,576 | 1,330,689 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $16,138,999 | 1,336,010 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,837,120 | 429,516 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $2,896,088 | 451,808 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,812,012 | 794,354 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,171,273 | 2,426,263 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,956,547 | 912,515 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $907,295 | 477,524 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $783,713 | 275,956 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,771,227 | 120,328 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,431,584 | 78,186 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,528,240 | 117,211 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,004,625 | 68,324 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,341,373 | 63,366 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $250,168 | 8,887 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $319,137 | 16,570 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $37,315 | 2,904 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||